Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 6.12
+0.22 (3.73%)
Mar 31, 2025, 3:54 PM CET
Hyloris Pharmaceuticals Revenue
In the year 2024, Hyloris Pharmaceuticals had annual revenue of 10.04M EUR with 138.30% growth. Hyloris Pharmaceuticals had revenue of 5.40M in the half year ending December 31, 2024, with 181.65% growth.
Revenue
10.04M
Revenue Growth
+138.30%
P/S Ratio
n/a
Revenue / Employee
204.94K
Employees
49
Market Cap
171.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.17B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 465.75M |
| Nyxoah | 4.52M |
| Onward Medical | -188.00K |
| Sequana Medical NV | 433.50K |